Search

Search Results

• 

  New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis

  Mehrie H. Patel, Alok A. Khorana

  16-05-2024

  326

  PDF: 173
• 

  Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy

  Gary E. Raskob

  16-05-2024

  390

  PDF: 162
• 

  Combined oral contraceptives and the risk of venous thromboembolism carriers of antithrombin, protein C or S deficiency: Sub-analysis of a prospective cohort study

  Daniela Tormene, Elena Campello, Chiara Simion, Anna Poretto, Paolo Prandoni, Paolo Simioni

  03-11-2022

  762

  PDF: 250
• 

  Venous thromboembolism and mortality in patients with hematological malignancies

  Kristen M. Sanfilippo, Tzu-Fei Wang

  16-05-2024

  386

  PDF: 135
• 

  Circulating albumin-to-fibrinogen ratio may be a risk indicator for venous thromboembolism: findings from a population-based prospective cohort study

  Setor K. Kunutsor, Sudhir Kurl, Ari Voutilainen, Jari Laukkanen

  14-07-2022

  957

  PDF: 206
• 

  Venous thromboembolism prophylaxis in orthopedic surgery: a narrative review

  Sarah Gallitto, Thomas C. Varkey, Jacob Lahti

  13-12-2024

  297

  PDF: 73
• 

  Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry

  Paolo Prandoni, Franca Bilora, Raffaele Pesavento, Giorgina Salgueiro, Angeles Blanco-Molina, Raquel Lòpez-Reyes, Manuel Monreal, and the RIETE Investigators

  23-05-2022

  5113

  PDF: 421

  APPENDIX: 97
• 

  Location of metastasis and complications in patients with venous thromboembolism and cancer: a systematic review

  Maria Barca-Hernando, Victor Garcia-Garcia, Luis Jara-Palomares

  16-05-2024

  329

  PDF: 112
• 

  Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

  Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli

  22-03-2022

  896

  PDF: 311

  APPENDIX: 59
• 

  Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

  Agnes Y.Y. Lee

  29-02-2024

  1273

  PDF: 218
• 

  Pleiotropic effects of anti-thrombotic therapies: have direct oral anticoagulants any anti-inflammatory effect?

  Anna Maria Gori, Eleonora Camilleri, Alessia Bertelli, Angela Rogolino, Francesca Cesari, Elena Lotti, Tommaso Capobianco, Walther Iannotti, Betti Giusti , Rossella Marcucci

  14-12-2022

  684

  PDF: 288
• 

  Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

  Marcello Di Nisio, Matteo Candeloro, Nicola Potere, Ettore Porreca, Jeffrey I. Weitz

  16-05-2024

  507

  PDF: 210
• 

  Machine learning in cancer-associated thrombosis: hype or hope in untangling the clot

  Rushad Patell, Jeffrey I. Zwicker, Rohan Singh, Simon Mantha

  16-05-2024

  1004

  PDF: 207
• 

  Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review

  Ang Li, Emily Zhou

  16-05-2024

  494

  PDF: 187
• 

  Cancer-associated ischemic stroke: current knowledge and future directions

  Ronda Lun, Deborah M. Siegal

  16-05-2024

  1215

  PDF: 326
• 

  Cancer complicated by thrombosis and thrombocytopenia: still a therapeutic dilemma

  Yishi Tan, Marc Carrier, Nicola Curry, Michael Desborough, Kathryn Musgrave, Marie Scully, Tzu-Fei Wang, Mari Thomas, Simon J. Stanworth

  16-05-2024

  424

  PDF: 136
• 

  From rare to aware: confronting Lemierre syndrome

  Silvia Cardi, Filippo Catalani, Luca Valerio, Stefano Barco

  21-10-2024

  1510

  PDF: 310
• 

  Talking about assisted reproductive techniques and thromboembolic risk: everything we always wanted to know

  Giovanni Tiscia, Elvira Grandone

  13-09-2022

  2131

  PDF: 225
• 

  It’s definitely time to consider diet in its ultra-processing form as a major risk factor for thrombotic vascular disorders

  Marialaura Bonaccio, Licia Iacoviello, Maria Benedetta Donati

  03-08-2023

  993

  PDF: 175

• Distal deep vein thrombosis: is there a way out of this dark forest?

  Matteo Guarascio, Gerardo Nicola Pititto, Alessia Abenante, Marco Paolo Donadini

  04-09-2024

  480

  PDF: 154
• 

  Aspirin or low-molecular weight heparin for thromboprophylaxis after a fracture? That is the question

  Giuseppe Camporese, Paolo Prandoni, Walter Ageno

  17-05-2023

  653

  PDF: 343
• 

  Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?

  Marco P. Donadini, Walter Ageno

  15-04-2022

  1927

  PDF: 498